#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    B-cell small lymphocytic lymphoma Astrocytoma malignant Staphylococcal infection Vernal keratoconjunctivitis Immunodeficiency congenital Cardiac arrest Aspergillus infection Drug eruption Neuroendocrine carcinoma metastatic Fatty acid oxidation disorder Chronic graft versus host disease in intestine Arginase deficiency Urea cycle disorder T-cell type acute leukaemia Fibrous dysplasia of bone More trials…

    Learn about Rare Diseases

    Shprintzen-Goldberg syndrome Thrombotic thrombocytopenic purpura – Life with Disease Breast angiosarcoma Fragile X syndrome – Diagnostics Hepatic angiosarcoma – Life with Disease Waldenstrom’s macroglobulinaemia refractory – Life with Disease Adrenogenital syndrome – Basic Information Small intestine leiomyosarcoma – Basic Information Inclusion body myositis – Basic Information Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cusatuzumab Atenolol Pyridoxine Hydrochloride Bp Balcinrenone Vorasidenib Gsk4381562A Icosapent Ethyl Gen1053 Metyrapone Bp Vrdn-001 Anhydrous Benzoyl Peroxide Prucalopride Amantadine Hemisulfate Lebrikizumab Iobitridol Ontasameran Vitamin A Bp Calcium Polystyrene Sulfonate Fondaparinux Sodium M2Rlab More therapies…

    Learn about Your Condition

    Langerhans cell sarcoma Familial mediterranean fever Elderly Stress cardiomyopathy Cholangiocarcinoma Prostate cancer metastatic Vitiligo Malignant fibrous histiocytoma Mantle cell lymphoma Fibromyalgia Colorectal cancer stage IV Post procedural hypotension Autoimmune uveitis Acute respiratory failure Intellectual disability More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Testing Personalized Drug Combination Treatment to Reduce Deaths in Patients with Severe Acute Infections

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Infection
    Investigated Drugs:
    • Acetylcysteine
    • Ferric Derisomaltose
    • Hydrocortisone
    Denmark

  • Study of RSV vaccine and pneumococcal vaccine combination for patients aged 60 and older with chronic obstructive pulmonary disease

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 10A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 11A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 12F Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    Denmark

  • Study of Intravenous Immunoglobulin Added to Standard Treatment for COVID-19 in Patients with Severely Weakened Immune System Due to B-cell Problems

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Nirmatrelvir
    • Remdesivir
    • Human Normal Immunoglobulin
    Sweden

  • Testing the Immune Response to Trivalent Inactivated Influenza Vaccine in People with Obesity and Type 2 Diabetes

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Influenza
    • Type 2 diabetes mellitus
    • Obesity
    Investigated Drugs:
    • INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
    • Influenza A/Victoria/4897/2022 Ivr-238 (H1N1), Inactivated
    • Influenza Virus B/Austria/1359417/2021-Like Strain (B/Austria/1359417/2021, Bvr-26)
    Sweden

  • Testing Remdesivir in Hospitalized Adult Patients with Tick-Borne Encephalitis to Measure Effects on Brain Cell Damage

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Mannitol
    Sweden

  • A Study of Doravirine for Early Treatment of West Nile Virus Infection in Patients at Risk of Disease Worsening

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Doravirine
    Italy
Previous Page
1 … 16 17 18 19 20 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!